Portola Pharmaceuticals, Inc. (PTLA) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:

Not Rated

No Current Ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
beginner rater beginner rater 03/23/2016 1 Year $29.39 $38.51 +31.03% 31 Ended
Comments: Adexenant alpha approval highly likely, a lot will depend on betrixiban data in early april.
laurvp laurvp 06/11/2015 1 month $44.94 $46.44 +3.34% 3 Ended
Asclepius Asclepius 05/12/2015 1 Year $37.85 $23.40 -38.18% -38 Ended
Comments: Don't underestimate when the sun rise on the horizon.
Vozniak Vozniak 03/04/2014 1 week $23.25 $26.75 +15.05% 15 Ended
bnkhoa bnkhoa 09/25/2013 1 Year $23.92 $27.25 +13.92% 13 Ended
Comments: Factor Xa antidote meets a significant unmet need

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.